Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitor...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-03-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327276473188352 |
|---|---|
| author | Yury Ivanovich Suntsov |
| author_facet | Yury Ivanovich Suntsov |
| author_sort | Yury Ivanovich Suntsov |
| collection | DOAJ |
| description | Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 agonists in treatment of T2DM. Conclusion. Percentage of DPP-4 inhibitors and GLP-1 analogues in T2DM treatment patterns remains nominal and does not exceed0.2%, which is significantly lower than in the majority of other countries. Insulin analogues are prescribed considerably more frequentlyand currently appear to be the most promising agents for treatment of T2DM. |
| format | Article |
| id | doaj-art-dcc60c358f43471d88cbed7d0e3e67d5 |
| institution | Kabale University |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2012-03-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-dcc60c358f43471d88cbed7d0e3e67d52025-08-20T03:47:54ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782012-03-011516910.14341/2072-0351-59715929Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitusYury Ivanovich Suntsov0Endocrinology Research Centre, MoscowAims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 agonists in treatment of T2DM. Conclusion. Percentage of DPP-4 inhibitors and GLP-1 analogues in T2DM treatment patterns remains nominal and does not exceed0.2%, which is significantly lower than in the majority of other countries. Insulin analogues are prescribed considerably more frequentlyand currently appear to be the most promising agents for treatment of T2DM.https://www.dia-endojournals.ru/jour/article/view/5971diabetes mellitus type 2insulin analoguesdpp-4 inhibitorsglp-1 agonists |
| spellingShingle | Yury Ivanovich Suntsov Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus Сахарный диабет diabetes mellitus type 2 insulin analogues dpp-4 inhibitors glp-1 agonists |
| title | Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus |
| title_full | Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus |
| title_fullStr | Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus |
| title_full_unstemmed | Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus |
| title_short | Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus |
| title_sort | modern antihyperglycemic agents prescribed in russia for type 2 diabetes mellitus |
| topic | diabetes mellitus type 2 insulin analogues dpp-4 inhibitors glp-1 agonists |
| url | https://www.dia-endojournals.ru/jour/article/view/5971 |
| work_keys_str_mv | AT yuryivanovichsuntsov modernantihyperglycemicagentsprescribedinrussiafortype2diabetesmellitus |